1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Zimmermann, N. Jung, G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C3 H7 N O2 89.093 D-ALANINE D-peptide linking C4 H9 N O2 103.120 D-ALPHA-AMINOBUTYRIC ACID D-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 246 809 819 10.1111/j.1432-1033.1997.00809.x 9219543 The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR. 1997 IX Eur.J.Biochem. EJBCAI 0262 0014-2956 228 786 10.1111/J.1432-1033.1995.TB20324.X 7737178 The Tetracyclic Lantibiotic Actagardine. 1H-NMR and 13C-NMR Assignments and Revised Primary Structure 1995 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1882.296 LANTIBIOTIC ACTAGARDINE 1 nat polymer no yes (DAL)SGWVC(DBB)L(DBB)IECG(DBB)VICAC ASGWVCTLTIECGTVICAC A polypeptide(L) n n n n n n n n n n n n n n n n n n n sample 31048, 31049 1 19 69484 Actinoplanes liguriensis citation entity_name_com entity_src_nat pdbx_database_status struct_conn struct_ref struct_ref_seq repository Initial release Version format compliance Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Other Database references Derived calculations Other Source and taxonomy Structure summary 1 0 1997-10-15 1 1 2011-06-14 1 2 2011-07-13 1 3 2011-07-27 1 4 2012-12-12 1 5 2019-12-11 _citation.page_last _citation.pdbx_database_id_DOI _citation.title _entity_src_nat.pdbx_beg_seq_num _entity_src_nat.pdbx_end_seq_num _entity_src_nat.pdbx_ncbi_taxonomy_id _entity_src_nat.pdbx_organism_scientific _pdbx_database_status.process_site _struct_conn.pdbx_leaving_atom_flag _struct_ref.db_code _struct_ref.db_name _struct_ref.pdbx_align_begin _struct_ref.pdbx_db_accession _struct_ref_seq.pdbx_db_accession SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN MEOH/H2O MIXTURE SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN DPC MICELLES SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN BOUND TO LIPID II IN DPC MICELLES CRYSTAL STRUCTURE OF THE TUPE B LANTIBIOTIC MERSACIDIN SOLUTION STRUCTURE OF THE LANTIBIOTIC EPILANCIN 15X SOLUTION STRUCTURE OF NISIN AND LIPID II COMPLEX SOLUTION STRUCTURE OF THE LANTIBIOTIC CINNAMYCIN COMPLEXED WITH LYSOPHOSPHATIDYLETHANOLAMINE SOLUTION STRUCTURE OF LCH-ALPHA PEPTIDE FROM TWO-COMPONENT LANTIBIOTIC SYSTEM LICHENICIDIN VK21 A1 SOLUTION STRUCTURE OF LCH-BETA PEPTIDE FROM TWO-COMPONENT LANTIBIOTIC LICHENICIDIN VK21 A2 Y BNL 1997-05-14 REL REL Lantibiotic ACTAGARDINE IS A TRICYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR AND SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE THIOETHER BONDS WITH CYSTEINE RESULT IN THREE RING STRUCTURES. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR. ACTAGARDINE Oligopeptide LEAST RESTRAINT VIOLATIONS, BEST RELAXATION MATRIX R- FACTORS 100 15 NOESY 3.0 296 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. DISTANCE GEOMETRY, ITERATIVE RELAXATION MATRIX REFINEMENT, RESTRAINED MOLECULAR DYNAMICS BOELENS,BONVIN refinement IRMA structure solution BRUKER UXNMR UXNMR structure solution BIOSYM FELIX 2.3 structure solution BIOSYM NMRCHITECT NMRCHITECT 600 Bruker AMX2-600 DAL 1 n 1 DAL 1 A SER 2 n 2 SER 2 A GLY 3 n 3 GLY 3 A TRP 4 n 4 TRP 4 A VAL 5 n 5 VAL 5 A CYS 6 n 6 CYS 6 A DBB 7 n 7 DBB 7 A LEU 8 n 8 LEU 8 A DBB 9 n 9 DBB 9 A ILE 10 n 10 ILE 10 A GLU 11 n 11 GLU 11 A CYS 12 n 12 CYS 12 A GLY 13 n 13 GLY 13 A DBB 14 n 14 DBB 14 A VAL 15 n 15 VAL 15 A ILE 16 n 16 ILE 16 A CYS 17 n 17 CYS 17 A ALA 18 n 18 ALA 18 A CYS 19 n 19 CYS 19 A software_defined_assembly PQS 1 monomeric A DBB 7 POST-TRANSLATIONAL MODIFICATION A DBB 7 THR A DBB 9 POST-TRANSLATIONAL MODIFICATION A DBB 9 THR A DBB 14 POST-TRANSLATIONAL MODIFICATION A DBB 14 THR 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A VAL CYS 5 6 139.32 1 A A CYS DBB 6 7 146.55 1 A A ALA CYS 18 19 102.52 2 A A VAL CYS 5 6 138.81 2 A A ALA CYS 18 19 103.53 3 A A TRP VAL 4 5 148.48 3 A A VAL CYS 5 6 137.43 3 A A ALA CYS 18 19 103.40 4 A A VAL CYS 5 6 140.91 4 A A CYS DBB 6 7 149.26 4 A A ALA CYS 18 19 99.60 5 A A TRP VAL 4 5 146.69 5 A A VAL CYS 5 6 139.48 5 A A ALA CYS 18 19 101.68 6 A A VAL CYS 5 6 140.88 6 A A ALA CYS 18 19 103.44 7 A A VAL CYS 5 6 141.34 7 A A CYS DBB 6 7 148.89 7 A A ALA CYS 18 19 99.40 8 A A VAL CYS 5 6 141.29 8 A A CYS DBB 6 7 148.49 8 A A ALA CYS 18 19 103.07 9 A A VAL CYS 5 6 139.12 9 A A CYS DBB 6 7 146.62 9 A A ALA CYS 18 19 103.31 10 A A VAL CYS 5 6 141.24 10 A A CYS DBB 6 7 149.20 10 A A ALA CYS 18 19 100.95 11 A A VAL CYS 5 6 141.35 11 A A CYS DBB 6 7 148.70 11 A A ALA CYS 18 19 102.14 12 A A VAL CYS 5 6 141.76 12 A A CYS DBB 6 7 146.73 12 A A ALA CYS 18 19 103.81 13 A A VAL CYS 5 6 140.21 13 A A ALA CYS 18 19 102.20 14 A A VAL CYS 5 6 141.32 14 A A CYS DBB 6 7 148.02 14 A A ALA CYS 18 19 101.95 15 A A VAL CYS 5 6 138.06 15 A A CYS DBB 6 7 148.25 15 A A ALA CYS 18 19 105.03 15 7.22 1.20 111.50 118.72 A A A CB CA C CYS CYS CYS 17 17 17 N 1 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 1 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 2 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 2 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 3 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 3 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 4 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 4 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 5 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 5 A A C OXT CYS CYS 19 19 0.199 0.019 1.229 1.428 N 6 A A CD OE2 GLU GLU 11 11 0.120 0.011 1.252 1.372 N 6 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 7 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 7 A A C OXT CYS CYS 19 19 0.199 0.019 1.229 1.428 N 8 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 8 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 9 A A CD OE2 GLU GLU 11 11 0.120 0.011 1.252 1.372 N 9 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 10 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 10 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 11 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 11 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 12 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 12 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 13 A A CD OE2 GLU GLU 11 11 0.120 0.011 1.252 1.372 N 13 A A C OXT CYS CYS 19 19 0.199 0.019 1.229 1.428 N 14 A A CD OE2 GLU GLU 11 11 0.119 0.011 1.252 1.371 N 14 A A C OXT CYS CYS 19 19 0.199 0.019 1.229 1.428 N 15 A A CD OE2 GLU GLU 11 11 0.120 0.011 1.252 1.372 N 15 A A C OXT CYS CYS 19 19 0.200 0.019 1.229 1.429 N 1 A VAL 5 -77.67 -75.92 1 A CYS 6 52.47 119.22 1 A LEU 8 -110.30 64.22 1 A VAL 15 -139.02 -36.07 2 A VAL 5 -78.40 -74.07 2 A CYS 6 48.17 123.08 2 A DBB 7 96.61 -34.64 2 A LEU 8 -96.71 42.49 2 A VAL 15 -135.97 -49.00 3 A VAL 5 -79.20 -70.59 3 A CYS 6 30.45 124.95 3 A LEU 8 -115.97 61.26 3 A VAL 15 -141.59 -33.95 4 A VAL 5 -77.99 -76.19 4 A CYS 6 49.71 120.05 4 A DBB 7 97.17 -33.70 4 A LEU 8 -98.27 55.33 4 A VAL 15 -136.57 -51.07 5 A VAL 5 -78.84 -74.64 5 A CYS 6 38.11 121.09 5 A LEU 8 -111.26 61.21 5 A VAL 15 -136.57 -49.41 6 A VAL 5 -78.54 -73.86 6 A CYS 6 44.11 122.70 6 A DBB 7 97.05 -33.19 6 A LEU 8 -98.20 43.09 6 A VAL 15 -135.98 -47.96 7 A VAL 5 -77.84 -76.09 7 A CYS 6 52.31 119.34 7 A DBB 7 97.66 -33.97 7 A LEU 8 -98.07 55.30 7 A VAL 15 -136.57 -50.94 8 A VAL 5 -77.81 -76.08 8 A CYS 6 52.04 119.21 8 A DBB 7 98.04 -33.35 8 A LEU 8 -98.24 55.14 8 A VAL 15 -140.63 -34.35 8 A CYS 17 -79.52 -162.91 9 A VAL 5 -77.69 -76.02 9 A CYS 6 51.74 120.48 9 A LEU 8 -107.63 63.11 9 A VAL 15 -134.27 -50.02 10 A VAL 5 -77.91 -75.65 10 A CYS 6 48.35 117.75 10 A LEU 8 -95.77 51.62 10 A VAL 15 -137.37 -46.80 11 A VAL 5 -77.78 -76.12 11 A CYS 6 52.34 119.34 11 A DBB 7 97.68 -33.98 11 A LEU 8 -97.74 55.01 11 A VAL 15 -134.18 -51.96 12 A VAL 5 -77.82 -75.55 12 A CYS 6 48.09 120.10 12 A LEU 8 -110.27 64.53 12 A VAL 15 -133.42 -48.88 13 A VAL 5 -78.62 -74.15 13 A CYS 6 47.22 123.36 13 A DBB 7 96.52 -33.64 13 A LEU 8 -97.85 53.71 13 A VAL 15 -142.20 -33.76 13 A CYS 17 -80.00 -166.13 14 A VAL 5 -77.94 -75.61 14 A CYS 6 48.13 120.16 14 A LEU 8 -109.95 61.30 14 A VAL 15 -136.30 -50.60 15 A VAL 5 -78.55 -73.65 15 A CYS 6 47.25 122.93 15 A VAL 15 -132.44 -44.90 15 A CYS 17 -86.60 -158.74 LANTIBIOTIC ACTAGARDINE NMR STRUCTURE OF THE LANTIBIOTIC ACTAGARDINE 1 N N covale 1.350 both A DAL 1 A C DAL 1 1_555 A SER 2 A N SER 2 1_555 covale 1.814 none A DAL 1 A CB DAL 1 1_555 A CYS 6 A SG CYS 6 1_555 covale 1.318 one A CYS 6 A C CYS 6 1_555 A DBB 7 A N DBB 7 1_555 covale 1.351 both A DBB 7 A C DBB 7 1_555 A LEU 8 A N LEU 8 1_555 covale 1.843 none A DBB 7 A CB DBB 7 1_555 A CYS 12 A SG CYS 12 1_555 covale 1.346 one A LEU 8 A C LEU 8 1_555 A DBB 9 A N DBB 9 1_555 covale 1.823 none A DBB 9 A CB DBB 9 1_555 A CYS 17 A SG CYS 17 1_555 covale 1.353 both A DBB 9 A C DBB 9 1_555 A ILE 10 A N ILE 10 1_555 covale 1.348 one A GLY 13 A C GLY 13 1_555 A DBB 14 A N DBB 14 1_555 covale 1.824 none A DBB 14 A CB DBB 14 1_555 A CYS 19 A SG CYS 19 1_555 covale 1.358 both A DBB 14 A C DBB 14 1_555 A VAL 15 A N VAL 15 1_555 ANTIBIOTIC ANTIBIOTIC, LANTIBIOTIC, ANTIMICROBIAL, BACTERIOCIN, THIOESTER, TRANSMEMBRANE PORE 1AJ1 PDB 1 1 1AJ1 1 19 1AJ1 1 19 1AJ1 A 1 1 19 1 P 1